Xstrahl, whose corporate vision is “to help eradicate cancer”, is a leading designer and manufacturer of medical devices in the treatment of cancers and dermatological disorders, as well as a pioneer in the development of advanced X–ray systems for pre-clinical radiation biology research.
For over 15 years, Xstrahl medical systems have reliably supported healthcare professionals and patients in over 500 clinics around the world.
The company is headquartered in Britain and has facilities in the US. Exporting to over 25 countries, its customers are mainly hospitals and universities.
KEY DEAL CHARACTERISTICS
Vendor Instigated MBI
Complex international group structure
Structured deal comprising cash and loan notes
“THE WHOLE PROCESS, TOOK TWELVE MONTHS FROM FIRST CONTACT, THE WRITING OF THE INVESTMENT MEMORANDUM, CIRCULATION TO INTERESTED PARTIES AND OBTAINING A REALISTIC PRICE FOR THE BUSINESS FOLLOWING EXTENSIVE DUE DILIGENCE BY THE ACQUIRER’S PROFESSIONAL ADVISORS WAS HANDLED WITH PROFESSIONALISM AND UNSTINTING RESOURCES BY THE LOCKDUTTON TEAM”.
Executive Chairman, Xstrahl